Probiotics Can Boost the Antitumor Immunity of CD8⁺T Cells in BALB/c Mice and Patients with Colorectal Carcinoma

Figure 1

Immunohistochemical and flow cytometry results of human colorectal carcinoma. (a–d) The immunohistochemical results of consecutive sections of the same patient’s colorectal cancer tissue; (a, b) the results of CD4⁺T cell staining; (c, d) the results of CD8⁺T cell staining. (e) The statistical figure of CD4⁺T cells between the probiotic treatment group and the nonprobiotic treatment group. (f) The statistical figure of CD8⁺T cells between the probiotic treatment group and the nonprobiotic treatment group. (g, h) Flow cytometric results of CD4⁺T cells and CD8⁺T cells. (i, j) Statistical results. Note: group A was treated with probiotics before surgery; group B was not treated with probiotics.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)